Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

BACKGROUND: Dysglycaemia defined as type 2 diabetes (T2DM) and impaired glucose tolerance (IGT), increases the risk of cardiovascular disease (CVD). The negative impact is more apparent in the presence of hypertension and/or dyslipidaemia. Thus, it seems reasonable to screen for dysglycaemia in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahim, Bahira, Gyberg, Viveca, De Bacquer, Dirk, Kotseva, Kornelia, De Backer, Guy, Schnell, Oliver, Tuomilehto, Jaakko, Wood, David, Rydén, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781265/
https://www.ncbi.nlm.nih.gov/pubmed/29368616
http://dx.doi.org/10.1186/s12933-018-0665-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781265/
https://www.ncbi.nlm.nih.gov/pubmed/29368616
http://dx.doi.org/10.1186/s12933-018-0665-4

Ejemplares similares